T 0188/15 (Plant protein hydrolysate/NOVO NORDISK) of 31.10.2018
- European Case Law Identifier
- ECLI:EP:BA:2018:T018815.20181031
- Date of decision
- 31 October 2018
- Case number
- T 0188/15
- Petition for review of
- -
- Application number
- 06708017.6
- IPC class
- C12N 5/00C12P 21/02
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- PRODUCTION OF A POLYPEPTIDE IN A SERUM-FREE CELL CULTURE LIQUID CONTAINING PLANT PROTEIN HYDROLYSATE
- Applicant name
- Novo Nordisk Health Care AG
- Opponent name
- Baxter Healthcare S.A.
- Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention R 100(1)European Patent Convention R 84(1)
- Keywords
- Lapse of patent in all designated states - termination of the appeal proceedings
- Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal proceedings are terminated.